Microsatellite instability in colorectal cancer: Considerations for molecular diagnosis and high-throughput screening of archival tissues

Clinical Chemistry

Volumn 50, Issue 6, 2004, Pages 1082-1086

  Salto Tellez, Manuel ^a,b   Lee, Soo Chin ^b   Chiu, Lily L ^b   Lee, Chi Kuen ^a   Yong, May Chin ^b   Koay, Evelyn S C ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DINUCLEOTIDE REPEAT; DNA EXTRACTION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HIGH THROUGHPUT SCREENING; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MALE; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; MOLECULAR BIOLOGY; SEQUENCE ANALYSIS;

ADULT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE REPEATS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 2642518732     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.030700     Document Type: Article

References (15)

1. de la Chapelle A. Microsatellite instability. N Engl J Med 2003;349:209-10.
2. Hemminki A, Mecklin JP, Jarvinen H, Aaltonen LA, Joensuu H. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000;119:921-8.
3. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349:247-57.
4. Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 2001;158:527-35.
5. Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999;23:1248-55.
6. Boland CR. Hereditary nonpolyposis colorectal cancer. In: Vogelstein B, Kinzler KW, eds. The genetic basis of human cancer, 2nd ed. New York: McGraw-Hill, 2002:315.
7. Salto-Tellez M, Zhang D, Chiu LL, Wang SC, Nilsson B, Koay ES. Immunocytochemistry versus molecular fingerprinting of metastases. Cytopathology 2003;14:186-90.
8. Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2000;2:20-8.
9. Bocker T, Diermann J, Friedl W, Gebert J, Holinski-Feder E, Karner-Hanusch J, et al. Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res 1997;57:4739-43.
10. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
11. Zhang D, Salto-Tellez M, Putti TC, Do E, Koay ES. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod Pathol 2003;16:79-84.
12. Chia KS, Seow A, Lee HP. Cancer incidence in Singapore 1993-1997. Singapore Cancer Registry Report No. 5. Singapore: Singapore Cancer Registry, 2000.
13. Jass JR. Diagnosis of hereditary non-polyposis colorectal cancer. Histopathology 1998;32:491-7.
14. Raevaara TE, Vaccaro C, Abdel-Rahman WM, Mocetti E, Bala S, Lonnqvist KE, et al. Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein. Gastroenterology 2003;125:501-9.
15. Farrington SM, Lin-Goerke J, Ling J, Wang Y, Burczak JD, Robbins DJ, et al. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet 1998;63:749-59.